DPhil Projects
The Radcliffe Department of Medicine is now open to applications for entry in October 2026. DPhil projects available will be published from early September.
| Title | |
|---|---|
| 2026 Antanaviciute Group (iCase): The GI Chronicle project: Exploring the effect of age on intestinal epithelial & immune function 2026 Antanaviciute Group (iCase): The GI Chronicle project: Exploring the effect of age on intestinal epithelial & immune function | Agne Antanaviciute |
| 2026 Zhang Group (MRC Enterprise iCase): Developing Accountable AI for Automated Cardiovascular MR Processing towards Precision Diagnostic Reporting 2026 Zhang Group (MRC Enterprise iCase): Developing Accountable AI for Automated Cardiovascular MR Processing towards Precision Diagnostic Reporting | Qiang Zhang |
| 2026 Antanaviciute Group: Decrypting human intestinal development 2026 Antanaviciute Group: Decrypting human intestinal development | Agne Antanaviciute |
| 2026 Chakraverty Group: Identifying novel CD4+ T cell platforms for immunotherapy 2026 Chakraverty Group: Identifying novel CD4+ T cell platforms for immunotherapy | Ronjon Chakraverty |
| 2026 Davies Group: Genomics and Genome Editing 2026 Davies Group: Genomics and Genome Editing | James Davies |
| 2026 Goriely Group: Investigating the role of genetic mosaicism in congenital disease 2026 Goriely Group: Investigating the role of genetic mosaicism in congenital disease | Anne Goriely |
| 2026 Kassouf Group: Understanding the principles of gene expression in health and disease 2026 Kassouf Group: Understanding the principles of gene expression in health and disease | Mira Kassouf |
| 2026 Koohy Group: Decoding the underlying rules of T cell response by AI and Machine-Learning strategies 2026 Koohy Group: Decoding the underlying rules of T cell response by AI and Machine-Learning strategies | Hashem Koohy |
| 2026 Mead Group: Gene-Environment Initiated Disease Progression in Myeloproliferative Neoplasms 2026 Mead Group: Gene-Environment Initiated Disease Progression in Myeloproliferative Neoplasms | Adam Mead |
| 2026 Ogg Group: Discovery of new approaches to treat skin inflammation 2026 Ogg Group: Discovery of new approaches to treat skin inflammation | Graham Ogg |
| 2026 Nerlov Group: Single Cell Biology and Machine Learning in Blood Development, Cancer and Ageing 2026 Nerlov Group: Single Cell Biology and Machine Learning in Blood Development, Cancer and Ageing | Claus Nerlov |
| 2026 Sharma Group: Comparative Analysis of TCR-Mediated Cytotoxicity Using Genome-Wide CRISPR Screens to Identify Host Factors in Natural vs. Vaccine-Induced Immunity 2026 Sharma Group: Comparative Analysis of TCR-Mediated Cytotoxicity Using Genome-Wide CRISPR Screens to Identify Host Factors in Natural vs. Vaccine-Induced Immunity | Sumana Sharma |
| 2026 Simmons Group: Engineering Intestinal Mesenchymal Niches to Promote Epithelial Barrier Health Through Life 2026 Simmons Group: Engineering Intestinal Mesenchymal Niches to Promote Epithelial Barrier Health Through Life | Alison Simmons |
| 2026 Twigg Group: Building the skull – normal and abnormal development 2026 Twigg Group: Building the skull – normal and abnormal development | Stephen Twigg |
| 2026 Vyas Group: New Immune Therapies For Acute Myeloid Leukaemia (AML) And Other Cancers 2026 Vyas Group: New Immune Therapies For Acute Myeloid Leukaemia (AML) And Other Cancers | Paresh Vyas |
| 2026 Akbar Group: Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential 2026 Akbar Group: Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential | Naveed Akbar |
| 2026 Antoniades Group: Cross-talk between adipose tissue and the cardiovascular system in humans - Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets 2026 Antoniades Group: Cross-talk between adipose tissue and the cardiovascular system in humans - Using Artificial Intelligence to design precision Imaging diagnostics and discover novel therapeutic targets | Charalambos Antoniades |
| 2026 Bhattacharya Group: Targeting chemokine inhibitors to the inflamed islet 2026 Bhattacharya Group: Targeting chemokine inhibitors to the inflamed islet | Shoumo Bhattacharya |
| 2026 Cai Group: Metabolic and inflammatory crosstalk in the tumour microenvironment 2026 Cai Group: Metabolic and inflammatory crosstalk in the tumour microenvironment | Shijie Cai |
| 2026 Choudhury Group: Immuno-modulation and inflammation reprogramming in cardio-metabolic disease 2026 Choudhury Group: Immuno-modulation and inflammation reprogramming in cardio-metabolic disease | Robin Choudhury |
| 2026 Christodoulides Group: Deciphering the Role of White and Brown Adipocytes in Cardiometabolic Diseases 2026 Christodoulides Group: Deciphering the Role of White and Brown Adipocytes in Cardiometabolic Diseases | Constantinos Christodoulides |
| 2026 Grist Group: A Unified Deep Learning Framework for Multimodal Imaging of the Healthy Human Lung 2026 Grist Group: A Unified Deep Learning Framework for Multimodal Imaging of the Healthy Human Lung | James Grist |
| 2026 Hodson Group: Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues. 2026 Hodson Group: Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues. | David Hodson |
| 2026 Kini Group: AI approaches to understanding the treatment of genetic epilepsies 2026 Kini Group: AI approaches to understanding the treatment of genetic epilepsies | Usha Kini |
| 2026 Leeson Group: Imaging in Preventive Cardiology Research 2026 Leeson Group: Imaging in Preventive Cardiology Research | Paul Leeson |
| 2026 Lewis Group: Spatial biology to understand and rejuvenate failing hearts 2026 Lewis Group: Spatial biology to understand and rejuvenate failing hearts | Andrew Lewis |
| 2026 Piechnik Group: Experimental and clinical translation of advanced quantitative cardiovascular magnetic resonance imaging techniques 2026 Piechnik Group: Experimental and clinical translation of advanced quantitative cardiovascular magnetic resonance imaging techniques | Stefan Piechnik |
| 2026 Raman Group: Pioneering Precision Medicine in Hypertrophic Cardiomyopathy: Advanced Imaging, Machine Learning, and Translational Research for Early Detection and Targeted Therapies 2026 Raman Group: Pioneering Precision Medicine in Hypertrophic Cardiomyopathy: Advanced Imaging, Machine Learning, and Translational Research for Early Detection and Targeted Therapies | Betty Raman |
| 2026 Reilly Group: Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation 2026 Reilly Group: Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation | Svetlana Reilly |
| 2026 Toepfer Group: Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 2026 Toepfer Group: Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9 | Christopher Toepfer |
| 2026 Tyler Group: Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart 2026 Tyler Group: Development and Application of Hyperpolarized Magnetic Resonance Imaging in the Study of the Diseased Heart | Damian Tyler |
| 2026 Valkovic Group: Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy and supported by AI 2026 Valkovic Group: Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy and supported by AI | Ladislav Valkovic |
| 2026 Watkins Group: Genetic therapies for Inherited Heart Muscle Disease 2026 Watkins Group: Genetic therapies for Inherited Heart Muscle Disease | Hugh Watkins |
| 2026 Zhang Group: Artificial Intelligence for cardiovascular imaging and clinical big data 2026 Zhang Group: Artificial Intelligence for cardiovascular imaging and clinical big data | Qiang Zhang |
| 2026 Bannard Group: Antibody-Mediated Immunity following Infection and Vaccination (B Cell Immunology) 2026 Bannard Group: Antibody-Mediated Immunity following Infection and Vaccination (B Cell Immunology) | |
| 2026 Raman Group (MRC Enterprise iCase): Development of Cardiac Diffusion Tensor Imaging for Clinical Evaluation of Cardiomyopathies 2026 Raman Group (MRC Enterprise iCase): Development of Cardiac Diffusion Tensor Imaging for Clinical Evaluation of Cardiomyopathies | Betty Raman |
| 2026 Lewis Group (MRC Enterprise iCase): High throughput human systems for target discovery and validation in tissue fibrosis 2026 Lewis Group (MRC Enterprise iCase): High throughput human systems for target discovery and validation in tissue fibrosis | Andrew Lewis |